Can genes predict liver damage from MS drug?
NCT ID NCT01118130
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study enrolled 300 people with multiple sclerosis who were taking beta-interferon. Researchers compared the genes of those who developed liver injury to those who did not, aiming to find genetic markers that predict this side effect. No new drug or treatment was tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors predict which MS patients are at risk for liver damage from beta-interferon, leading to safer prescribing.
What could go wrong
This is an observational study, not a treatment trial. It only looks for genetic links, so it won't directly change care. Results may not apply to all MS patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dalhousie MS Research Unit
Halifax, Nova Scotia, Canada
-
Hôpital Notre-Dame MS clinic
Montreal, Quebec, Canada
-
London Health Sciences Centre MS clinic
London, Ontario, Canada
-
MS Clinic UBC Hospital
Vancouver, British Columbia, V6T 2B5, Canada
-
Winnipeg Health Sciences Centre
Winnipeg, Manitoba, Canada